CVE:VM

Voyageur Pharmaceuticals - VM Stock Forecast, Price & News

C$0.08

+0.01 (+7.14%)

(As of 12/8/2022 09:34 AM ET)

Add

Compare

Today's Range: C$0.08
▼
C$0.08
50-Day Range: C$0.07
▼
C$0.10
52-Week Range: C$0.06
▼
C$0.20

Volume: 6,100 shs
Average Volume: 109,495 shs
Market Capitalization: C$8.61 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: C$0.55

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.

Receive VM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

VM Stock News Headlines

December 8, 2022 | proactiveinvestors.com

Voyageur Pharmaceuticals launches SmoothX barium contrast media in Canada

December 5, 2022 | proactiveinvestors.com

Voyageur Pharmaceuticals issues deferred share units to directors under equity incentive compensation plan

November 1, 2022 | proactiveinvestors.com

Voyageur Pharmaceuticals completes design for Alberta's first carbon-neutral pharmaceutical facility

October 31, 2022 | finance.yahoo.com

Voyageur Pharmaceuticals Ltd. Designs Carbon Neutral Pharmaceutical Manufacturing Plant with a Carbon Credit De-Carbonization Strategy for Customers

August 21, 2022 | reuters.com

Voyageur Pharmaceuticals Ltd

September 15, 2021 | benzinga.com

Voyageur Pharmaceuticals Ltd., Announces The Creation of a New Scientific Advisory Board With World Class Leading Physicians

April 6, 2021 | theglobeandmail.com

Voyageur Pharmaceuticals Ltd. Announces Two Health Canada Approvals and Issuance of Product Licenses for MultiX Ba; Radiographic Barium Contrast

April 5, 2021 | baystreet.ca

Pharma Stock Pops After Receiving Approval From Health Canada (HC)

December 29, 2020 | baystreet.ca

Voyageur, Arbor, BevCanna at 52-Week Highs on News

December 26, 2020 | markets.businessinsider.com

Japan Asset Marketing Co.,Ltd. Stock , JASSF

October 20, 2020 | theglobeandmail.com

Voyageur Minerals' Joint Venture Company, ImagingX Pharmaceuticals, Submits Third Barium Contrast Product to Health Canada for Registration

June 15, 2020 | www.bloomberg.com

Voyageur Minerals Ltd Joint Venture Company, ImagingX Pharmaceuticals, Submits Second Barium Contrast Product to Health Canada

May 23, 2020 | www.barrons.com

Voyageur Pharmaceuticals Ltd.

May 11, 2020 | www.benzinga.com

Voyageur Secures Exclusive Rights To One Of The Worlds Rarest Pharmaceutical Minerals, Creating A New Era In Carbon Based Drug Development

March 20, 2020 | www.globenewswire.com

Voyageur Restructures its ImagingX Joint Venture

February 26, 2020 | www.globenewswire.com

Voyageur Pharmaceuticals Announces its “From The Earth To The Bottle” Iodine Contrast Strategy

February 18, 2020 | www.globenewswire.com

Voyageur Pharmaceuticals Implements Frances Creek Environmental Strategy for Bulk Sample and Future Quarry Production

July 29, 2019 | www.globenewswire.com

Voyageur Closes First Tranche of Non-Brokered Private Placement

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive VM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Industry: Industrial Metals & Minerals
Sub-Industry: N/A
Sector: Basic Materials
Current Symbol: CVE:VM
CUSIP: N/A
CIK: N/A
Web: www.voyageurminerals.ca
Phone: 587-779-6166
Fax: N/A
Employees: N/A
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: C$0.55
High Stock Price Forecast: C$0.55
Low Stock Price Forecast: C$0.55
Forecasted Upside/Downside: +633.3%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 1.75
Current Ratio: 1.24
Quick Ratio: 0.84

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: C$0.00 per share
Price / Cash Flow: 35.00
Book Value: C$0.02 per share
Price / Book: 4.41

Miscellaneous

Outstanding Shares: 114,764,000
Free Float: N/A
Market Cap: C$8.61 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Brent Willis Bsc.Eng (Age 51)
Pres, CEO & Director
Comp: $110k

Mr. Bradley Craig Willis P.Eng. (Age 51)
Founder, COO & Director
Comp: $110k

Mr. Albert Deslauriers
Chief Financial Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

VM Stock - Frequently Asked Questions

Should I buy or sell Voyageur Pharmaceuticals stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Voyageur Pharmaceuticals in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" VM shares.
View VM analyst ratings or view top-rated stocks.
What is Voyageur Pharmaceuticals' stock price forecast for 2023?: 1 equities research analysts have issued 12 month price objectives for Voyageur Pharmaceuticals' stock. Their VM share price forecasts range from C$0.55 to C$0.55. On average, they predict the company's share price to reach C$0.55 in the next twelve months. This suggests a possible upside of 633.3% from the stock's current price.
View analysts price targets for VM or view top-rated stocks among Wall Street analysts.
How have VM shares performed in 2022?: Voyageur Pharmaceuticals' stock was trading at C$0.09 at the start of the year. Since then, VM stock has decreased by 16.7% and is now trading at C$0.08.
View the best growth stocks for 2022 here.
What other stocks do shareholders of Voyageur Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Voyageur Pharmaceuticals investors own include Agile Therapeutics (AGRX), Sierra Oncology (SRRA), Achillion Pharmaceuticals (ACHN), LINE (LN), Littelfuse (LFUS), Howard Hughes (HHC), EQT (EQT), Deckers Outdoor (DECK), Cranswick (CWK) and Cirrus Logic (CRUS).

What is Voyageur Pharmaceuticals' stock symbol?: Voyageur Pharmaceuticals trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VM."
How do I buy shares of Voyageur Pharmaceuticals?: Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Voyageur Pharmaceuticals' stock price today?: One share of VM stock can currently be purchased for approximately C$0.08.
How much money does Voyageur Pharmaceuticals make?: Voyageur Pharmaceuticals (CVE:VM) has a market capitalization of C$8.61 million.
How can I contact Voyageur Pharmaceuticals?: The official website for the company is www.voyageurminerals.ca. The company can be reached via phone at 587-779-6166.

This page (CVE:VM) was last updated on 12/8/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial